Marketed products
Vectura receives revenues from its pharmaceutical company partners in respect of its portfolio of eight revenue-generating, marketed products, comprising both respiratory and non-respiratory products. This income is used to help offset the cost of Vectura's own non-clinical and clinical-stage product develoment programmes.
